共 29 条
[1]
Burchfiel C.M., Reed D.M., Marcus E.B., Strong J.P., Hayashi T., Association of diabetes mellitus with coronary aterosclerosis and myocardial lesions: An autopsy study from the Honolulu Heart Program, Am J Epidemiol, 137, pp. 1328-1340, (1993)
[2]
Uusitupa M., Mustonen J.N., Airaksinen K.E., Diabetic heart muscle disease, Ann Med, 22, pp. 377-386, (1990)
[3]
Diabetes Control T., Trial Research Group C., The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus, N Engl J Med, 329, pp. 977-986, (1993)
[4]
Rubler S., Dlugash J., Yeceoglu Y.Z., Kumral T., Branwood A.W., Grishman A., New type of cardiomyopathy associated with diabetic glomerulosclerosis, Am J Cardiol, 30, pp. 595-602, (1972)
[5]
Loimaala A., Groundstroem K., Majahalme S., Nenonen A., Vuori I., Impaired myocardial function in newly onset Type 2 diabetes associates with arterial stiffness, Eur J Echocardiography, 7, 5, pp. 341-347, (2006)
[6]
Fang Z.Y., Yuda S., Anderson V., Short L., Case C., Marwick T.H., Echocardiographic detection of early diabetic myocardial disease, J Am Coll Cardiol, 41, pp. 611-617, (2003)
[7]
Vinereanu D., Nicolaides E., Boden L., Payne N., Jones C.J.H., Fraser A.G., Conduit arterial stiffness is associated with impaired left ventricular subendocardial function, Heart, 89, pp. 449-451, (2003)
[8]
Hillis G.S., Moller J.E., Pellikka P.A., Gersh B.J., Wright R.S., Ommen S.R., Reeder G.S., Oh J.K., Noninvasive estimation of left ventricular filling pressure by E/e' is a powerful predictor of survival after acute myocardial infarction, J Am Coll Cardiol, 43, pp. 360-367, (2004)
[9]
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS33), Lancet, 352, pp. 837-852, (1998)
[10]
Patel R., Nagueh S.F., Tsybouleva N., Abdellatif M., Lutucuta S., Kopelen H.A., Quinones M.A., Zoghbi W.A., Entman M.L., Roberts R., Marian A.J., Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy, Circulation, 104, pp. 317-324, (2001)